《肿瘤学家》.2006年.第4期

　

• Outcome of Patients with HER2-Positive Advanced Breast Cancer Progressing During Trastuzumab-Based Therapy
• Capecitabine Monotherapy: Safe and Effective Treatment for Metastatic Breast Cancer
• Chemotherapeutic Approaches for Targeting Cell Death Pathways
• Pegylated Liposomal Doxorubicin Consolidation Therapy after Platinum/Paclitaxel-Based Chemotherapy for Suboptimally Debulked, Advanced-Stage
• T-Cell/Histiocyte-Rich B-Cell Lymphoma: Biology, Diagnosis, and Management
• Burkitt’s Lymphoma: Clinicopathologic Features and Differential Diagnosis
• Introduction to a Special Series of Unique Entities Within the Spectrum of Large-Cell Lymphoma
• Darbepoetin Alfa Administered Every Three Weeks Is Effective for the Treatment of Chemotherapy-Induced Anemia
• The Promise of the Human Papillomavirus Vaccine Does Not Confer Immunity Against Ethical Reflection
• Clinical Implications of EGFR Expression in the Development and Progression of Solid Tumors: Focus on Non-Small Cell Lung Cancer
• The Molecular Perspective: Estrogen Sulfotransferase
• TNF- in Cancer Treatment: Molecular Insights, Antitumor Effects, and Clinical Utility